86 related articles for article (PubMed ID: 29749488)
1. C‑Myc inhibitor 10058‑F4 increases the efficacy of dexamethasone on acute lymphoblastic leukaemia cells.
Lv M; Wang Y; Wu W; Yang S; Zhu H; Hu B; Chen Y; Shi C; Zhang Y; Mu Q; Ouyang G
Mol Med Rep; 2018 Jul; 18(1):421-428. PubMed ID: 29749488
[TBL] [Abstract][Full Text] [Related]
2. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Aiolos in Nalm-6 acute lymphoblastic leukaemia cells reduces apoptosis by suppressing phosphatase and tensin homologue deleted on chromosome 10 and activating the phosphatidylinositol-3-kinase/Akt signalling pathway.
Wang R; Guo G; Li H; Li X; Yu Y; Li D
Mol Med Rep; 2015 May; 11(5):3457-64. PubMed ID: 25608224
[TBL] [Abstract][Full Text] [Related]
4. Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK.
Liu Y; Ge J; Li Q; Gu L; Guo X; Ma ZG; Zhu YP
Neoplasma; 2013; 60(1):101-10. PubMed ID: 23067223
[TBL] [Abstract][Full Text] [Related]
5. c-Myc promotes tumor proliferation and anti‑apoptosis by repressing p21 in rhabdomyosarcomas.
Zhang J; Song N; Zang D; Yu J; Li J; Di W; Guo R; Zhao W; Wang H
Mol Med Rep; 2017 Oct; 16(4):4089-4094. PubMed ID: 28765944
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.
Medh RD; Wang A; Zhou F; Thompson EB
Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786
[TBL] [Abstract][Full Text] [Related]
8. Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells.
Noh EJ; Kang SW; Shin YJ; Choi SH; Kim CG; Park IS; Wheatley DN; Min BH
Int J Cancer; 2004 Nov; 112(3):502-8. PubMed ID: 15382078
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.
Evangelisti C; Cappellini A; Oliveira M; Fragoso R; Barata JT; Bertaina A; Locatelli F; Simioni C; Neri LM; Chiarini F; Lonetti A; Buontempo F; Orsini E; Pession A; Manzoli L; Martelli AM; Evangelisti C
J Cell Physiol; 2018 Mar; 233(3):1796-1811. PubMed ID: 28777460
[TBL] [Abstract][Full Text] [Related]
10. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation.
Palanichamy JK; Tran TM; Howard JM; Contreras JR; Fernando TR; Sterne-Weiler T; Katzman S; Toloue M; Yan W; Basso G; Pigazzi M; Sanford JR; Rao DS
J Clin Invest; 2016 Apr; 126(4):1495-511. PubMed ID: 26974154
[TBL] [Abstract][Full Text] [Related]
11. Beating the Clock in T-cell Acute Lymphoblastic Leukemia.
Carroll WL; Aifantis I; Raetz E
Clin Cancer Res; 2017 Feb; 23(4):873-875. PubMed ID: 28007775
[TBL] [Abstract][Full Text] [Related]
12. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia.
Pikman Y; Alexe G; Roti G; Conway AS; Furman A; Lee ES; Place AE; Kim S; Saran C; Modiste R; Weinstock DM; Harris M; Kung AL; Silverman LB; Stegmaier K
Clin Cancer Res; 2017 Feb; 23(4):1012-1024. PubMed ID: 28151717
[No Abstract] [Full Text] [Related]
14. Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells.
Carlet M; Janjetovic K; Rainer J; Schmidt S; Panzer-Grümayer R; Mann G; Prelog M; Meister B; Ploner C; Kofler R
BMC Cancer; 2010 Nov; 10():638. PubMed ID: 21092265
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells.
Ausserlechner MJ; Obexer P; Böck G; Geley S; Kofler R
Cell Death Differ; 2004 Feb; 11(2):165-74. PubMed ID: 14576768
[TBL] [Abstract][Full Text] [Related]
16. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines.
Wang XW; Xu YH
Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia.
Bhadri VA; Trahair TN; Lock RB
J Paediatr Child Health; 2012 Aug; 48(8):634-40. PubMed ID: 22050419
[TBL] [Abstract][Full Text] [Related]
18. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
20. BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia.
Li Y; Deutzmann A; Choi PS; Fan AC; Felsher DW
Oncotarget; 2016 May; 7(19):26926-34. PubMed ID: 27095570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
